Skip to main content
Equibles

Candriam S.C.A.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1537014 STRASSEN, N4
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$43,976,468
+$7,739,537 QoQ
Shares Held
260,926
-5.1% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#69
of 774 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $150,994,107 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (29.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page 		260,926 $43,976,468
2 ZTS
Zoetis Inc.
 474,935 $34,128,829
3 UTHR
UNITED THERAPEUTICS Corp
 53,684 $29,087,601
4 BCRX
Biocryst Pharmaceuticals Inc
 2,514,949 $25,149,490
5 TEVA
Teva Pharmaceutical Industries Ltd
 550,523 $18,651,719

All Filings in NBIX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,976,468 260,926
2026-03-31 $36,236,931 275,064
2025-12-31 $41,569,805 293,096
2025-09-30 $40,379,605 287,645
2025-06-30 $37,524,875 298,551
2025-03-31 $36,590,904 330,840
2024-12-31 $41,492,178 303,972
2024-09-30 $55,679,028 483,241
2024-06-30 $64,080,841 465,467
2024-03-31 $43,539,137 315,684
2023-12-31 $48,737,892 369,899
2023-09-30 $42,439,275 377,238
2023-06-30 $41,531,228 440,416
2023-03-31 $42,226,959 417,180
2022-12-31 $32,149,903 269,172
2022-09-30 $28,833,997 271,481
2022-06-30 $32,258,958 330,929
2022-03-31 $28,144,406 300,207
2021-12-31 $26,395,290 309,913
2021-09-30 $7,817,911 81,513
2021-06-30 $7,930,898 81,493
2021-03-31 $58,350 600
2021-03-31 $15,741,760 161,869
2020-12-31 $57,510 600
2020-12-31 $15,515,143 161,869
2020-09-30 $15,028,077 156,282
2020-06-30 $19,066,404 156,282
2020-03-31 $16,164,597 186,766